Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New CDK9/cyclin T1 inhibitors identified at Algen Biotechnologies

Dec. 9, 2021

Spago completes regulatory preclinical program with Tumorad

Dec. 7, 2021

Incyte describes new mutant GTPase KRAS inhibitors

Dec. 7, 2021

Jiangsu Simcere Pharmaceutical R&D discovers SERDs

Dec. 7, 2021

New ACSS2 inhibitors discovered at Metabomed

Dec. 7, 2021

Jiangsu Protelight Pharmaceutical & Biotechnology patents amino acid derivatives

Dec. 7, 2021

Orion completes OB-004 lead optimization

Dec. 3, 2021

J2H Biotech synthesizes new compounds for liver cancer

Dec. 3, 2021

PMV Pharmaceuticals identifies new TP53 mutant stabilizers

Dec. 3, 2021

Accutar Biotechnology patents EGFR and/or HER2 inhibitors

Dec. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.